BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27488836)

  • 1. Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.
    Yang M; Ayuningtyas A; Kenfield SA; Sesso HD; Campos H; Ma J; Stampfer MJ; Chavarro JE
    Cancer Causes Control; 2016 Sep; 27(9):1153-61. PubMed ID: 27488836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of plasma fatty acids and risk of prostate cancer.
    Gann PH; Hennekens CH; Sacks FM; Grodstein F; Giovannucci EL; Stampfer MJ
    J Natl Cancer Inst; 1994 Feb; 86(4):281-6. PubMed ID: 8158682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
    Chavarro JE; Stampfer MJ; Campos H; Kurth T; Willett WC; Ma J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):95-101. PubMed ID: 18199715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
    Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
    Dahm CC; Gorst-Rasmussen A; Crowe FL; Roswall N; Tjønneland A; Drogan D; Boeing H; Teucher B; Kaaks R; Adarakis G; Zylis D; Trichopoulou A; Fedirko V; Chajes V; Jenab M; Palli D; Pala V; Tumino R; Ricceri F; van Kranen H; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Luján-Barroso L; Larrañaga N; Chirlaque MD; Ardanaz E; Johansson M; Stattin P; Khaw KT; Wareham N; Wark PA; Norat T; Riboli E; Key TJ; Overvad K
    Am J Clin Nutr; 2012 Dec; 96(6):1354-61. PubMed ID: 23134890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
    Crowe FL; Appleby PN; Travis RC; Barnett M; Brasky TM; Bueno-de-Mesquita HB; Chajes V; Chavarro JE; Chirlaque MD; English DR; Gibson RA; Giles GG; Goodman GE; Henning SM; Kaaks R; King IB; Kolonel LN; Kristal AR; Neuhouser ML; Park SY; Severi G; Siddiq A; Stampfer MJ; Stattin P; Tangen CM; Tjønneland A; Trichopoulos D; Tumino R; Wilkens LR; Key TJ; Allen NE;
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25210201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer.
    Chavarro JE; Kenfield SA; Stampfer MJ; Loda M; Campos H; Sesso HD; Ma J
    Am J Epidemiol; 2013 Oct; 178(8):1246-55. PubMed ID: 23989197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
    Bassett JK; Severi G; Hodge AM; MacInnis RJ; Gibson RA; Hopper JL; English DR; Giles GG
    Int J Cancer; 2013 Oct; 133(8):1882-91. PubMed ID: 23575905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
    Crowe FL; Allen NE; Appleby PN; Overvad K; Aardestrup IV; Johnsen NF; Tjønneland A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Zavitsanou A; Trichopoulos D; Sacerdote C; Palli D; Tumino R; Agnoli C; Kiemeney LA; Bueno-de-Mesquita HB; Chirlaque MD; Ardanaz E; Larrañaga N; Quirós JR; Sánchez MJ; González CA; Stattin P; Hallmans G; Bingham S; Khaw KT; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
    Am J Clin Nutr; 2008 Nov; 88(5):1353-63. PubMed ID: 18996872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk.
    Yang M; Sesso HD; Colditz GA; Ma J; Stampfer MJ; Chavarro JE
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
    King IB; Kristal AR; Schaffer S; Thornquist M; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):988-92. PubMed ID: 15824175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica.
    Jackson MD; Walker SP; Simpson-Smith CM; Lindsay CM; Smith G; McFarlane-Anderson N; Bennett FI; Coard KC; Aiken WD; Tulloch T; Paul TJ; Wan RL
    Cancer Causes Control; 2012 Jan; 23(1):23-33. PubMed ID: 21984307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte membrane phospholipid fatty acid concentrations and risk of colorectal adenomas: a case-control nested in the French E3N-EPIC cohort study.
    Cottet V; Collin M; Gross AS; Boutron-Ruault MC; Morois S; Clavel-Chapelon F; Chajès V
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1417-27. PubMed ID: 23704475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study.
    Saadatian-Elahi M; Toniolo P; Ferrari P; Goudable J; Akhmedkhanov A; Zeleniuch-Jacquotte A; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1353-60. PubMed ID: 12433711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort.
    de Vogel S; Meyer K; Fredriksen Å; Ulvik A; Ueland PM; Nygård O; Vollset SE; Tell GS; Tretli S; Bjørge T
    Int J Epidemiol; 2013 Feb; 42(1):201-10. PubMed ID: 23508410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.
    Park SY; Wilkens LR; Henning SM; Le Marchand L; Gao K; Goodman MT; Murphy SP; Henderson BE; Kolonel LN
    Cancer Causes Control; 2009 Mar; 20(2):211-23. PubMed ID: 18821021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study.
    Kojima M; Wakai K; Tokudome S; Suzuki K; Tamakoshi K; Watanabe Y; Kawado M; Hashimoto S; Hayakawa N; Ozasa K; Toyoshima H; Suzuki S; Ito Y; Tamakoshi A;
    Am J Epidemiol; 2005 Mar; 161(5):462-71. PubMed ID: 15718482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.